1. Home
  2. ICU vs BFRI Comparison

ICU vs BFRI Comparison

Compare ICU & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICU
  • BFRI
  • Stock Information
  • Founded
  • ICU 2018
  • BFRI 1997
  • Country
  • ICU United States
  • BFRI United States
  • Employees
  • ICU N/A
  • BFRI N/A
  • Industry
  • ICU Biotechnology: Pharmaceutical Preparations
  • BFRI Biotechnology: Pharmaceutical Preparations
  • Sector
  • ICU Health Care
  • BFRI Health Care
  • Exchange
  • ICU Nasdaq
  • BFRI Nasdaq
  • Market Cap
  • ICU 9.5M
  • BFRI 7.9M
  • IPO Year
  • ICU N/A
  • BFRI 2021
  • Fundamental
  • Price
  • ICU $0.66
  • BFRI $1.04
  • Analyst Decision
  • ICU
  • BFRI Strong Buy
  • Analyst Count
  • ICU 0
  • BFRI 1
  • Target Price
  • ICU N/A
  • BFRI $2.75
  • AVG Volume (30 Days)
  • ICU 5.7M
  • BFRI 180.2K
  • Earning Date
  • ICU 08-12-2025
  • BFRI 08-13-2025
  • Dividend Yield
  • ICU N/A
  • BFRI N/A
  • EPS Growth
  • ICU N/A
  • BFRI N/A
  • EPS
  • ICU N/A
  • BFRI N/A
  • Revenue
  • ICU $428,000.00
  • BFRI $37,997,000.00
  • Revenue This Year
  • ICU $754.07
  • BFRI $11.75
  • Revenue Next Year
  • ICU $100.09
  • BFRI $17.09
  • P/E Ratio
  • ICU N/A
  • BFRI N/A
  • Revenue Growth
  • ICU N/A
  • BFRI 14.28
  • 52 Week Low
  • ICU $0.31
  • BFRI $0.54
  • 52 Week High
  • ICU $9.09
  • BFRI $2.22
  • Technical
  • Relative Strength Index (RSI)
  • ICU 45.72
  • BFRI 67.33
  • Support Level
  • ICU $0.53
  • BFRI $0.99
  • Resistance Level
  • ICU $0.94
  • BFRI $1.14
  • Average True Range (ATR)
  • ICU 0.10
  • BFRI 0.09
  • MACD
  • ICU 0.01
  • BFRI 0.01
  • Stochastic Oscillator
  • ICU 30.91
  • BFRI 65.52

About ICU SeaStar Medical Holding Corporation

SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.

About BFRI Biofrontera Inc.

Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.

Share on Social Networks: